• Policy
• First Depakote generic is being reviewed for reimb in KOR
• by Lee, Tak-Sun Dec 8, 2023 05:55am

• Company
• Former Janssen Korea President Cherry Huang goes to China
• by Eo, Yun-Ho Dec 8, 2023 05:55am

• Company
• Jemperli reimbursed as immunotherapy for endometrial cancer
• by Dec 8, 2023 05:55am

• InterView
• 'Janssen’s strong in autoimmune diseases for a reason'
• by Eo, Yun-Ho Dec 7, 2023 01:28pm

• Company
• JW Pharm Hemlibra's sales tops KRW 10 bil for the 1st time
• by Chon, Seung-Hyun Dec 7, 2023 05:47am

• Opinion
• [Reporter’s View] CSO is a double-edged sword
• by Kim, Jin-Gu Dec 7, 2023 05:47am

• Company
• Bemarituzumab is granted ODD status in Korea
• by Eo, Yun-Ho Dec 7, 2023 05:47am

• Company
• Dong-A and Pfizer win Industry Ad-PR Awards
• by Kim, Jin-Gu Dec 7, 2023 05:47am

• Policy
• HIRA’s reimb reevaluation results to be released on the 7th
• by Lee, Tak-Sun Dec 7, 2023 05:47am

• Policy
• Bill proposed to prioritize domestic drugs and vaccines
• by Lee, Jeong-Hwan Dec 6, 2023 06:00am